Pelthos Therapeutics Inc.

US$9.36As of Sun 8 Nov 2026, 12:00 UTC
AMEX:PTHSHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (40.41%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 3.44
PE TTM —
TSR TTM (71.64%)
Mkt cap US$35.83M
ROIC (102.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
24.38%
64.51%
Hold 2|3|2|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.10
0.11
0.12
13.09%
2.20%
15.43%
8.85%
Revenue$M
1.826
1.837
1.807
1.806
6.02%
3.94%
(0.15%)
(3.65%)
Peers (US$35.83M)
Cap (US$)
PE
36.15M
—
35.03M
61.89x
35.75M
26.42x
Capital
TTM
5Y
10Y
Leveragex
1.875
(0.076)
(0.054)
EBIT/Intx
0.176
3.306
2.469
Own earn%
28.00
(90.18)
(102.12)
Sh yield%
37.19
11.45
11.60
Owners
Insiders/Inst%
2.83
81.43
Short interest%
3.27
SBC / revenue%
0.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
57